Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Olga V. Lazareva"'
Autor:
Olga V. Lazareva
Publikováno v:
Russian Journal of Education and Psychology, Vol 14, Iss 6, Pp 81-95 (2023)
Purpose. The purpose of this article is to analyze innovative technologies used in foreign language classes and identify their advantages over traditional forms of education, as well as systematize their key features: practice-oriented nature, focus
Externí odkaz:
https://doaj.org/article/34af6e9b86dc45efa32a3489aa236cf1
Publikováno v:
Sovremennye Issledovaniâ Socialʹnyh Problem, Vol 13, Iss 3, Pp 82-101 (2021)
В данной статье анализируется концепция деятельности социально-общественных организаций в системе дополнительного образования пожил
Externí odkaz:
https://doaj.org/article/df8fcba13a654df18dbabe7e46eb6fe4
The specifics of the father's role in the american family: a traditional and new view of the problem
Autor:
Olga V. Lazareva
Publikováno v:
Yaroslavl Pedagogical Bulletin. 4:36-41
The article is devoted to the urgent problem of modern education – pedagogical parenting education, which is a part of the social policy of modern society. The parenting education is aimed at personal development. Both the subject and the object ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fe1781253034e373bc78ac3d0e007e3
https://doi.org/10.20323/1813-145x-2021-4-121-36-41
https://doi.org/10.20323/1813-145x-2021-4-121-36-41
Autor:
Olga Senderova, Ekatarina Yu. Chelysheva, Maria V. Galayko, Alexandr S. Luchinin, Anna G. Turkina, Hunan Julhakyan, L V Gavrilova, Anton Kulikovsky, Valentina Pepeliaeva, Olga V. Lazareva, Sergey Meresiy, Olga Yu. Vinogradova, Galina I. Milutina, Lyudmila B. Avdeeva, Sergey M. Kulikov, Elena B. Dasheeva
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:e328-e335
Russia took part in the multicenter population-based study (Europe) and included 6.8% adult patients with newly diagnosed chronic myeloid leukemia (CML). The objective of this study was to analyze the mortality in the Russian cohort of patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2119972ab36a62875942888051d98010
https://doi.org/10.1016/j.clml.2020.02.004
https://doi.org/10.1016/j.clml.2020.02.004
Autor:
Olga Senderova, Gysual Safuanova, Andrey Zaritsky, Elza Lomaia, Anton Kulikovsky, Elena Fedorova, Alexandr Korobkin, Marina Kozmina, Lubov Gavrilova, Eva Burnasheva, Elena Volodicheva, Galina Kuchma, Alexander S. Luchinin, Ludmila Napso, Dolgorzhap Dasheeva, Varvara I. Bakhtina, Ekaterina Chelysheva, Anna Lyamkina, Anton Shutilev, Marina Kosinova, Anatoly Golenkov, Vasilisa Skatova, Olga V. Lazareva, Svetlana Volkova, Sergei M. Kulikov, Tatiana Konstantinova, Sergey Voloshin, Vera Yablokova, Tatiana Klitochenko, Anna G. Turkina, Andrew Proidakov, Nataliya Glonina, Andrew Zhuravkov, Tatiana Chagorova, Olga Vinogradova
Publikováno v:
Blood. 138:5035-5035
The results of long-term follow-up of patients (pts) with chronic myeloid leukemia (CML) do not lose their importance. Data from routine clinical practice are of particular interest. The use of 1 st (imatinib, IM) and 2nd generation TKI (2G TKI) led
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a19128c61306200bf830a0b28868e780
https://doi.org/10.1182/blood-2021-151371
https://doi.org/10.1182/blood-2021-151371
Autor:
Sergei M. Kulikov, OYu Vinogradova, Alexander S. Luchinin, L V Gavrilova, MA Galaiko, A Tishchenko, SV Meresii, Olga V. Lazareva, Anna G. Turkina, V M Pepelyaeva, Olga Senderova, GI Milyutina, EYu Chelysheva, L B Avdeeva
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 2, Pp 65-74 (2017)
Background. Much attention has been paid to molecule-genetic diagnostics of chronic myeloid leukemia (CML) and its treatment using new highly effective methods of therapy. The baseline characteristics of patients at primary CML diagnosis are hardly d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8762dac182869b9afc23f4bef3eabc29
http://bloodjournal.ru/wp-content/uploads/2017/01/9.pdf
http://bloodjournal.ru/wp-content/uploads/2017/01/9.pdf
Autor:
Hunan Julhakyan, Galina I. Milutina, Oleg Shukhov, Lubov Gavrilova, Valentina Pepeliaeva, Olga Vinogradova, Alexander S. Luchinin, Anton Kulikovskiy, Lubov Avdeeva, Maria V. Galayko, Sergey Meresiy, Ekaterina Chelysheva, Olga Senderova, Sergey M. Kulikov, Anna G. Turkina, Elena B. Dasheeva, Olga V. Lazareva
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S298-S299
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2fbbb5ad4ea2509e119b9f505c82492
https://doi.org/10.1016/j.clml.2019.07.252
https://doi.org/10.1016/j.clml.2019.07.252
Autor:
Galina I. Milutina, Ekaterina Chelysheva, Sergei M. Kulikov, Valentina Pepeliaeva, L B Avdeeva, Anton Kulikovsky, Lubov Gavrilova, Olga Vinogradova, Sergey Meresiy, Dolgorzhap Dasheeva, Olga V. Lazareva, Alexander S. Luchinin, Anna G. Turkina, Olga Senderova
Publikováno v:
Blood. 134:5902-5902
Background: A success of the tyrosine kinase inhibitors (TKI) therapy in patients (pts) with chronic myeloid leukemia (CML) allowed to set a new goal: a treatment-free remission (TFR). A stable and long-lasting deep molecular response (DMR) is requir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5b90d338bacb27a4741ee02bea1b161
https://doi.org/10.1182/blood-2019-131430
https://doi.org/10.1182/blood-2019-131430
Autor:
Ekaterina Chelysheva, Oleg Shukhov, Anna G. Turkina, Sergey G. Kuznetsov, Anastasia Bykova, Svetlana Goryacheva, Olga V. Lazareva, Galina Gusarova, Alexandra Vorontsova, Tatyana Ivanova
Publikováno v:
Blood. 126:5141-5141
Background. The aim of chronic myeloid leukemia (CML) treatment with tyrosine kinase inhibitors (TKI) is not only effectiveness, but also safety. Long treatment duration makes the analysis of most significant complications very important. Pleural eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f3ae23b59a300713301e28dd116a070
https://doi.org/10.1182/blood.v126.23.5141.5141
https://doi.org/10.1182/blood.v126.23.5141.5141
Autor:
Sergey M. Kulikov, Irina A. Tischenko, Anna G. Turkina, Olga V. Lazareva, Ekaterina Chelysheva
Publikováno v:
Blood. 124:3140-3140
Introduction: Most surrogate endpoints are based on periodical measurement and the assessment of event time uses data censored by both sides. Kaplan-Maier (KM) estimators are calculated from right censored data and as result they are biased and sensi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5b0dc70ccca11808ac38646e66e8af1
https://doi.org/10.1182/blood.v124.21.3140.3140
https://doi.org/10.1182/blood.v124.21.3140.3140